Literature DB >> 27264145

Hematological profile of HIV patients in relation to immune status - a hospital-based cohort from Varanasi, North India.

Suresh Venkata Satya Attili, V P Singh, Madhukar Rai, Datla Vivekananda Varma, A K Gulati, Shyam Sundar.   

Abstract

OBJECTIVES: To study the spectrum of hematological manifestations and evaluate the relationship between various hematological manifestations and CD4 cell counts in a hospital-based cohort of HIV-infected adults in and around Varanasi, North India. MATERIALS-
METHODS: The clinical and hematological profiles of the patients attending the Infectious Disease Clinic, Varanasi, India were recorded. The relationship between CD4 counts and various hematological manifestations was analyzed.
RESULTS: A total of 470 HIV-infected individuals were followed for 830 person years of observation (PYO). Rate of hematological episodes was 1047 episodes per 1000 PYO. CD4 counts were significantly lower in individuals with severe anemia and neutropenia compared to those without. However, no relation could be established between thrombocytopenia and CD4 counts. In the above- mentioned population, CD4 levels were significantly lower in those with anemia/neutropenia harboring any particular disease compared to those who had the same disease without anemia/ neutropenia.
CONCLUSIONS: There is a strong negative association between CD4 counts and the severity of anemia and neutropenia in this population. They can be considered as good clinical indicators to predict and access the underlying immune status. Though fall in the CD4 levels during neutropenia is observed, it is difficult to comment since the estimations of CD4 rely on the total leukocyte counts. However, the relation between anemia and disease progression is straight forward and quite useful for the treating physician.

Entities:  

Year:  2008        PMID: 27264145

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN: 1300-7777            Impact factor:   1.831


  7 in total

1.  Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: A cross-sectional study.

Authors:  Negesso Duguma; Girum Tesfaye Kiya; Wondimagegn Adissu Maleko; Lealem Gedefaw Bimerew
Journal:  SAGE Open Med       Date:  2021-05-28

2.  Impact of malaria on hematological parameters in people living with HIV/AIDS attending the Laquintinie Hospital in Douala, Cameroon.

Authors:  Gervais Gouana Tchinda; Julius Atashili; Eric A Achidi; Henri L Kamga; Anna L Njunda; Peter M Ndumbe
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

3.  Anemia among Patients Attending Anti-retroviral Therapy at a Tertiary Care Center: A Descriptive Cross-sectional Study.

Authors:  Bibhant Shah; Lochan Karki; Rajesh Kumar Mandal
Journal:  JNMA J Nepal Med Assoc       Date:  2021-12-11       Impact factor: 0.556

4.  HIV symptom burden and anemia among HIV-positive individuals: cross-sectional results of a community-based positive living with HIV (POLH) study in Nepal.

Authors:  Catherine Martin; Kalpana Poudel-Tandukar; Krishna C Poudel
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

5.  Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced children.

Authors:  Yakob Gebregziabher Tsegay; Agerie Tadele; Zelalem Addis; Agersew Alemu; Mulugeta Melku
Journal:  HIV AIDS (Auckl)       Date:  2017-02-20

6.  Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.

Authors:  Christian Obirikorang; Francis A Yeboah
Journal:  J Biomed Sci       Date:  2009-11-18       Impact factor: 8.410

7.  The hematologic profile of Filipino HIV-infected individuals and its association with CD4 counts.

Authors:  Preeti Prerna M Vaswani; Issa Rufina Senga-Tang; Jean Rachel M Catapia; Cybele Lara R Abad; Teresita E Dumagay
Journal:  Hematol Transfus Cell Ther       Date:  2021-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.